Stryker Corporation (SYK)

Market Cap	124.41B
Revenue (ttm)	20.50B
Net Income (ttm)	3.17B
Shares Out	380.26M
EPS (ttm)	8.25
PE Ratio	39.69
Forward PE	27.33
Dividend	$3.20 (0.98%)
Ex-Dividend Date	Mar 27, 2024

Volume	229,563
Open	330.38
Previous Close	327.45
Day's Range	326.75 - 330.39
52-Week Range	249.98 - 361.41
Beta	0.91
Analysts	Strong Buy
Price Target	338.80 (+3.69%)
Earnings Date	Apr 30, 2024

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 26,700
• Stock Exchange: NYSE
• Ticker Symbol: SYK

Financial Performance

In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.

Analyst Forecast

According to 20 analysts, the average rating for SYK stock is "Strong Buy." The 12-month stock price forecast is $338.8, which is an increase of 3.69% from the latest price.

Price Target

$338.8

(3.69% upside)

Analyst Consensus: Strong Buy